EUCTR2017-002599-15-DK进行中（未招募）1 期
Effect of pyridostigmine (Mestinon®) on muscle strength in Myasthenia Gravis.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Acetylcholine-receptor antibody positive Myasthenia Gravis, Age 18-90 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 22
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Cardio-pulmonary disease, neuropathy, myopathy, malignant disease, pregnancy or breastfeeding
研究者
相似试验
Unknown
4 期
Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia GravisMyasthenia GravisNCT03510546University of Aarhus44
招募中
3 期
Investigating the effect of pyridostigmine in individuals with poor ovarian responseIRCT20100518003950N8Tehran University of Medical Sciences110
已完成
4 期
Administration of clinical doses of neostigmine, commonly used in anaesthesia, and assessment of its effects on muscle strength, using a dynamometer, in healthy awake volunteers.ACTRN12617001505392Australian Society of Anaesthetists21
招募中
3 期
Effect of pyridostigmine in stroke-related dysphagiaIRCT20230520058232N1Sanandaj University of Medical Sciences60
已完成
不适用
The contribution of myostatin related to the effects of exercise on bone metabolism in the elderlythe healthy elderlyJPRN-UMIN000012773Environmental Physiology for Exercise, Osaka City University Graduate School of Medicine40